Dissecting the Mechanism of T Cell Tolerance for More Effective Breast Cancer Vaccine Development

doi 10.21236/ada435335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation

PLoS ONE
Multidisciplinary
2016English

T-Cell Tolerance in Cancer

Immunotherapy
OncologyAllergyImmunology
2013English

Clinical Development of the E75 Vaccine in Breast Cancer

Breast Care
SurgeryOncology
2016English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

More T Cells Versus Better T Cells in Patients With Breast Cancer

Cancer Discovery
Oncology
2017English

Targeting the Tumour Microenvironment and T Cell Metabolism for Effective Cancer Immunotherapy

European Journal of Immunology
AllergyImmunology
2019English

Development of Foxp3+ Regulatory T Cell: Epigenetics and More…

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Development of a Novel Support System for More Effective and Safer Cancer Chemotherapy

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2006English

Immunotherapeutic Cell-Based Vaccine to Combat Metastatic Breast Cancer

2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy